Low HDL-C levels are commonly associated with increasing a person's risk of developing cardiovascular disease. However, a new study in the Journal of the American College of Cardiology suggests this may not be the case for all patient populations. 

In the first few weeks of open enrollment, new signups on the healthcare marketplace, healthcare.gov, are up nearly 40%, according to the Department of Health and Human Services (HHS).

The regions that displayed the most significant differentiations in susceptibility values are known to be associated with neurological conditions such as fatigue, insomnia, anxiety, depression, headaches and other cognitive issues—all common complaints among many COVID long haulers. 

Telehealth can provide significant value when it comes to managing and monitoring patients with CVD or suspected CVD. A new scientific statement from the American Heart Association explores the latest details on this evolving treatment option. 

However, researchers noted, there is still considerable room for improvement.

The companies were given 15 days to provide an adequate response to the FDA's warning. The agency said its next step could include legal action. 

The scans can be completed in less than five seconds and require less radiation than a traditional chest x-ray.  

Cian McCarthy, MD, Massachusetts General Hospital, and a member of the National Cardiovascular Data Registry (NCDR) Chest Pain-MI registry steering committee, explains a study of the NCDR data showing only 33% of hospitals are using high-sensitivity troponin.